Buckett, Linda K.
AstraZeneca (United Kingdom)
2 papers on CoChatORCID 0000-0002-2224-7886
Most cited papers
- Verified
Targeting KRAS-dependent tumors with AZD4785, a high-affinity therapeutic antisense oligonucleotide inhibitor of KRAS
Ross, S. J., Revenko, A. S., Hanson, L. L., Ellston, R., Staniszewska, A., Whalley, N., Pandey, S. K., Revill, M., Rooney, C., Buckett, L. K., et al. (2017) · Science Translational Medicine
Protein Kinase Regulation and GTPase SignalingRNA Interference and Gene Delivery
Cited by 177
- Verified
Discovery of a Potent, Selective, and Orally Efficacious Pyrimidinooxazinyl Bicyclooctaneacetic Acid Diacylglycerol Acyltransferase-1 Inhibitor
Birch, A. M., Birtles, S., Buckett, L. K., Kemmitt, P. D., Smith, G. J., Smith, T. J. D., Turnbull, A. V., & Wang, S. J. Y. (2009) · Journal of Medicinal Chemistry
Pharmacology and Obesity TreatmentLipid metabolism and biosynthesis
Cited by 77
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free